These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2259892)

  • 1. Effect of H-2 genes on expression of HLA-B27 and Yersinia-induced arthritis.
    Nickerson CL; Hogen KL; Luthra HS; David CS
    Scand J Rheumatol Suppl; 1990; 87():85-90; discussion 90. PubMed ID: 2259892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of HLA-B27 in transgenic mice is dependent on the mouse H-2D genes.
    Nickerson CL; Hanson J; David CS
    J Exp Med; 1990 Oct; 172(4):1255-61. PubMed ID: 2212952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of HLA-B27 in transgenic mice is controlled by the H-2D gene(s).
    Nickerson-Nutter CL; David CS
    Int J Cancer Suppl; 1991; 6():14-7. PubMed ID: 2066179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility of HLA-B27 transgenic mice to Yersinia enterocolitica infection.
    Nickerson CL; Luthra HS; Savarirayan S; David CS
    Hum Immunol; 1990 Aug; 28(4):382-96. PubMed ID: 2391253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of HLA-B27 in transgenic mice is controlled by gene(s) mapping between H-2D and H-2L loci.
    Nickerson-Nutter CL; Hogen KL; David CS
    Immunogenetics; 1992; 35(3):199-204. PubMed ID: 1537610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of human HLA-B27 transgene alters susceptibility to murine Theiler's virus-induced demyelination.
    Rodriguez M; Nickerson C; Patick AK; David CS
    J Immunol; 1991 Apr; 146(8):2596-602. PubMed ID: 2016520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of enterobacteria and HLA-B27 in spondyloarthropathies: studies with transgenic mice.
    Nickerson CL; Luthra HS; David CS
    Ann Rheum Dis; 1990 Jun; 49 Suppl 1():426-33. PubMed ID: 2115764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation between HLA-B27 and clinical features in patients with yersinia arthritis.
    Laitinen O; Leirisalo M; Skylv G
    Arthritis Rheum; 1977 Jun; 20(5):1121-4. PubMed ID: 869958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hierarchy in the assembly of HLA-B27 and HLA-Cw3 molecules in transgenic mice.
    Pedrinaci S; Hanson J; David C
    Immunogenetics; 1994; 39(2):130-7. PubMed ID: 8276456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA class-I-transgenic mice as model system to study MHC-restricted antigen recognition in man.
    Weiss EH; Schliesser G; Botteron C; McMichael A; Riethmüller G; Kievits F; Ivanyi P; Brem G
    Scand J Rheumatol Suppl; 1990; 87():91-6. PubMed ID: 2259893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-B27 heavy chains contribute to spontaneous inflammatory disease in B27/human beta2-microglobulin (beta2m) double transgenic mice with disrupted mouse beta2m.
    Khare SD; Hansen J; Luthra HS; David CS
    J Clin Invest; 1996 Dec; 98(12):2746-55. PubMed ID: 8981920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular inflammation in HLA-B27 transgenic mice reveals a potential role for MHC class I in corneal immune privilege.
    Lin A; Guo X; Inman RD; Sivak JM
    Mol Vis; 2015; 21():131-7. PubMed ID: 25684978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B27-transgenic mice and disease.
    Ivanyi P
    Scand J Rheumatol Suppl; 1990; 87():97. PubMed ID: 2259894
    [No Abstract]   [Full Text] [Related]  

  • 14. HLA phenotypes in patients with rheumatic fever, rheumatic heart disease, and Yersinia arthritis.
    Leirisalo M; Laitinen O; Tiilikainen A
    J Rheumatol Suppl; 1977; 3():78-83. PubMed ID: 266605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Yersinia arthritis: a clinical, immunological, and family study of 2 cases.
    Sheldon PJ; Mair NS; Fox E
    Ann Rheum Dis; 1982 Apr; 41(2):153-8. PubMed ID: 6978685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Host-microbe interaction in HLA-B27-associated diseases.
    Granfors K
    Ann Med; 1997 Apr; 29(2):153-7. PubMed ID: 9187232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of tumour necrosis factor and interleukin 1 by monocytes of patients with previous Yersinia arthritis.
    Repo H; Jäättelä M; Leirisalo-Repo M; Hurme M
    Clin Exp Immunol; 1988 Jun; 72(3):410-4. PubMed ID: 3262459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of hybridization between Yersinia enterocolitica and HLA-B27 DNA.
    Viitanen AM; Lahesmaa-Rantala R; Weiss E; Toivanen A
    J Rheumatol; 1988 Jul; 15(7):1123-5. PubMed ID: 3262758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A single nonamer from the Yersinia 60-kDa heat shock protein is the target of HLA-B27-restricted CTL response in Yersinia-induced reactive arthritis.
    Ugrinovic S; Mertz A; Wu P; Braun J; Sieper J
    J Immunol; 1997 Dec; 159(11):5715-23. PubMed ID: 9548516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unraveling the mystery of HLA-B27 association with human spondyloarthropathies using transgenic and knock out mice.
    Khare SD; Luthra HS; David CS
    Semin Immunol; 1998 Feb; 10(1):15-23. PubMed ID: 9529652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.